Rachelle Bernacki, MD, MS, is the Lead Faculty, Community of Practice, Serious Illness Care Program at Ariadne Labs. In addition, Rachelle is Director of Quality Initiatives, Psychosocial Oncology and Palliative Care at the Dana-Farber Cancer Institute and is a faculty member at Harvard Medical School. Rachelle is board certified in Palliative Medicine, Geriatrics, and Internal Medicine; she is the recipient of two Geriatric Academic Career Awards from the Health Resources and Services Administration. Rachelle led a successful initiative to increase access to palliative care at Brigham and Women’s Hospital and her team earned the Partners in Excellence Award for these efforts. She is a Fellow of the American Academy of Hospice and Palliative Medicine.
Rachelle received her B.S. from Cornell University, her M.S. from the University of Chicago where she completed the Robert Wood Johnson Clinical Scholars Program, and her M.D. from Johns Hopkins University School of Medicine.
BOSTON, MA – Across the United States, millions of individuals face serious, life-limiting illness like cancer, heart disease and stroke, respiratory disease and diabetes. The final year of life with serious illness can be filled with emotional distress and uncertainty about treatment options. When people with serious illness have conversations with their doctors and nurses… Continue reading New study on Serious Illness Care Program underscores significant benefit of more, better, and earlier conversations between clinicians and patients
Through support from the Cambia Health Foundation’s Sojourns Scholar Leadership Program, three Ariadne Labs faculty lead the way to advancing the field of palliative care in the U.S. Compared to other medical specialties, palliative care is young. In fact, American medical accreditors did not recognize Hospice and Palliative Medicine as a subspecialty until 2006. With… Continue reading Three Ariadne Labs faculty are recognized for their work to advance the field of palliative care